Agoracom

The Small Cap Epicenter

In Phase II Clinical Trials

Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.

Hub Controls

> Log In

Upload Photo
Edit Company Profile
Add a Link
Update Fast Facts
Add Management Bios
Private Messages
Edit My Profile
View/Edit My Portfolio

Email Updates

AGORACOM News Flash

AGORACOM Launches Portfolio Feature!

We are proud to announce that the much anticipated Portfolio feature is now live. Track your favorite US and Canadian stocks in one place., as well as, market indices and even your net wealth.

To access your portfolio, click on "My AGORACOM" at the very top of the page, and then click on "Portfolio" in the left hand navigation.

You can also access your portfolio by clicking on the "View/Edit My Portfolio" from within your "HUB Controls" on the left side of the page.

Thank-you for making AGORACOM the best small-cap community on the web. Look for more great tools and updates to help you. Post comments and feedback to George's blog.

Regards,
George, Paul and the AGORACOM Team

AlphaRx > Press Release

Agoracom Admin

Did you know? AGORACOM TV is a great place to find your next small cap investment

NEWS - AlphaRx Receives Notice of Allowance From the US Patent Office

Posted by: AGORACOM on September 12, 2006 09:42AM

MARKHAM, ON -- Sep 12, 2006 -- AlphaRx Inc. (OTC BB:ALRX.OB), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs, has received a Notice of Allowance from the United States Patent and Trademark Office for its patent application entitled ``Stabilization of Benzoyl Peroxide in Solution.``

Benzoyl peroxide (``BP``) is one of the most widely used compounds for acne treatment due to its significant antimicrobial activity, mild keratolytic and duct opening properties. The actions include a topical antimicrobial effect against infecting bacteria, the removal of the horny layer of the epidermis, as well as the removal of thickened sebum and other debris clogging follicular pores.

Benzoyl peroxide is water insoluble and this insolubility causes local skin irritation due to contact with crystalline benzoyl peroxide. This insolubility also markedly decreases benzoyl peroxide`s oxidative action. Benzoyl peroxide in solution is much more efficient than micronized BP suspensions for superficial treatment, but once dissolved, the BP in solution becomes extremely unstable.

About AlphaRx Inc.

AlphaRx is an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs that are insoluble or poorly soluble in water or have yet to be administrable to the human body with an acceptable delivery method. The Company`s product candidates address various pharmaceutical markets, including arthritis, tuberculosis, ocular infection & inflammation, hospital acquired pneumonia and sepsis.

Forward-Looking Statements:

This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.

This press release is available on the company`s official on-line investor relations site for investor commentary, feedback and questions.

Contact:

For more information, please contact:

Agora Investor Relations Corp.

Web: http://www.agoracom.com

E-mail: Email Contact

Did You Know?

AGORACOM members with a rank of Treasurer or higher can upload Links to company HUBs